Autonomous multimodal implantable endoscopic capsule for the gastrointestinal tr...
Autonomous multimodal implantable endoscopic capsule for the gastrointestinal tract
AUTOCAPSULE aims at demonstrating the viability of a technology for early diagnosis of Inflammatory Bowel Disease (IBD) and bowel cancer and for monitoring of treatment effectiveness at primary or secondary point of care. The tech...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
SUPCAM
New cost effective and minimally invasive endoscopic device...
1M€
Cerrado
CODIR
Colonic Disease Investigation by Robotic Hydro colonoscopy
3M€
Cerrado
SMART PILL
New optical functions for endoscopic capsules
244K€
Cerrado
EndoTheranostics
Multi-sensor Eversion Robot Towards Intelligent Endoscopic...
8M€
Cerrado
MURAB
MRI and Ultrasound Robotic Assisted Biopsy
4M€
Cerrado
Información proyecto AUTOCAPSULE
Duración del proyecto: 64 meses
Fecha Inicio: 2020-06-04
Fecha Fin: 2025-10-31
Líder del proyecto
UNIVERSITA DI PISA
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
4M€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
AUTOCAPSULE aims at demonstrating the viability of a technology for early diagnosis of Inflammatory Bowel Disease (IBD) and bowel cancer and for monitoring of treatment effectiveness at primary or secondary point of care. The technology vision is based on an untethered autonomous capsule that is both implantable in the gastro-intestinal (GI) tract for several weeks in order to monitor a specific area, and that can explore the GI tract for endoscopy in a point of care, through magnetic manipulation with an external robotic arm and limited expertise of the operator . The capsule is capable of multimodal sensing, including micro ultrasound imaging, white light imaging, ph monitoring and inflammation monitoring.
The GI system is highly complex, subject to frequent external stimulus through eating and digestion, and carries an extremely high burden of disease: 15 – 40% of the European population report functional GI conditions. However, the range of conditions encompassed is too diverse a target for immediate action and we will therefore focus on inflammatory bowel disease (IBD) and colorectal cancer. Even for those diseases alone, the affected European populations are large, with colorectal cancer being the most common cancer in men (30% of all new cancers) and second most common in women (25% of all new cancers) with a total of about 350,000 cases in the EU in 2012. Moreover, the burden on healthcare systems is rising worldwide, with increased screening cited as the primary reason.
In the course of the AUTOCAPSULE project two parallel tracks will be followed to demonstrate the technology vision, each focusing on a subset of the vision capsule features. One focuses on the development and demonstration of an untethered autonomous robotic capsule, capable of micro ultrasound imaging and white light imaging. The other focuses on the development and demonstration of an implantable capsule, capable of operating with sub-mW wireless power supply and of being parked in the GI tract for several weeks. AUTOCAPSULE will demonstrate capsules with partial complementary implementations of the technology vision and will show a path towards the fabrication and industrial development of the full vision capsule.